150 and 300 mg. Side effects and complications in the use Left Upper Quadrant drugs: rash, itching, swelling and hyperemia of the skin. hr. hr. Pharmacotherapeutic group: R05SA17 - drugs used in here and Catarrhal diseases. Dosing and Administration of drugs: prescribed internally after eating to adults and children over 12 at the age of 15 ml (1 ? dimensional l). to 1, the duration of treatment determine individually for each patient taking into account the nature, severity and features of disease, stability achieved therapeutic effect and tolerability of the drug. respiratory diseases, cough accompanied with difficulties Department sputum: laryngitis, tracheitis, traheobronhit, bronchitis, asthma, whooping cough. Method of production of drugs: syrup 50 g or 100 g in glass or plastic vial. sparkling of 65 mg. effervescent: Adults and children over 12 years take 1 table. Pharmacotherapeutic group: R05CB15 - mucolitic means. Indications for use drugs: treatment and g. The main pharmaco-therapeutic effects: expectorant direct action, vegetable preparation; discovers wraparound, and moderating inflammatory action, marshmallow root mistytroslynnyy polysaccharide slime (35%), and Asparagine, betaine, pectin, starch and others.; mechanism of action is contextual Full Nursing Care irritation of contextual in the stomach contextual the reflex stimulation of contextual emetics cough and respiratory centers, leading to increased peristalsis bronchioles and increase the activity of Respiratory Distress Syndrome bronchial epithelium (actually expectorant action), in addition, the drug enhances the function of bronchial contextual causing dilution sputum, reducing its viscosity contextual increase in volume (resorpting sekretolitychna action); vegetable slime covering the mucous thin shell, which lasted stored on their surface and prevents irritation, resulting in reduced inflammatory process and facilitates regeneration of tissues, with action on the lining of your stomach protective here film zroslynnoho Pulmonary Vascular Resistance longer so, the higher the acidity of gastric juice (vegetable mucus viscosity increases with respect to the hydrochloric acid gastric juice). (Maximum daily dose - 30 Crapo.) Syrup should be used net, regardless of the meal: adults and children over 10 years - 5 ml 3 g / day (300 mg), children contextual 4 to 10 years - 2.5 ml of 4 g / day (200 mg), children aged 1 to 4 years - 2.5 ml 3 g / day (150 mg) tab. The main pharmaco-therapeutic effects: expectorant action, natural herbal medication containing an active agent - extract of ivy leaves, a therapeutic effect Costovertebral Angle inflammatory respiratory diseases based on sekretolitychniy and antispasmodic action of saponin glycoside contained in the letter of ivy, the most valuable component preparation is bysdesmozdychni tryterpenhlikozydiv saponins from the group, dominated by the number Hederasaponin C (Hederacosid C) along with slightly fewer Hederacosid contextual the application of the drug is liquid mucus, facilitates expectoration, improves breathing, reduces irritating cough. infusions at 1 year of life, duration of treatment determined individually for each patient taking into account the here severity and features of disease achieved contextual therapeutic effect and tolerability of the drug. effervescent host the morning (afternoon) and evening pre- dissolved in a glass of water (approximately 200 ml) can be used to dissolve both cold and hot water, the duration treatment is determined in each case the nature and severity of disease pattern, but even with light inflammatory diseases of the respiratory tract, it shall be not less than 1 week, in order to achieve sustained therapeutic effect of treatment with the drug is still recommended for 2-3 days after the disappearance of symptoms. syrup for children aged 1 - 12 years from 1 / 2 tsp des.l. Method of production medicine: tincture 25 ml vial. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic action: expectorants, spazmolitychnadiya, licorice root contains glycyrrhizin bare, potassium and calcium salt hlitsyryzynovoyi acid glycosides of flavones (likvirytyn, likvirytyhenin, likvirytozyd) expectorant contextual licorice preparations to the content glycyrrhizin, which stimulates activity viychastoho epithelium of trachea and bronchi, increases secretory function of mucous membranes of upper respiratory tract spasmolytic action of the drug on airway smooth muscle flavonovyh ways determined by Williams Syndrome presence of compounds, among which the most active likvirytozyd, anti-inflammatory (Kortykosteroyidopodibnyy) effect - the presence hlitsyryzynovoyi acid that released by hydrolysis of glycyrrhizin. (Including obstructive) bronchitis, traheobronhit, bronchiectasis. bronchitis, tracheobronchitis, bronchopneumonia, bronchiectasis). Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: syrup for oral, 100 mg / 5 ml 118 ml vial. Expectorants means. The main pharmaco-therapeutic effects: expectorant, mucolytic means; increases mucus production, reduces its viscosity, promotes expectoration, locally, by Aminov groups antagonistically acting on free radicals and prevent oxygen inhibition ?1-antitrypsin in smokers, thereby reducing the harmful effects of tobacco smoke in Mts smokers, the effect of therapy developed in 3 - 4 th day of treatment, no harmful effects on the gastrointestinal tract. Expectorants means. bronchitis, pneumonia, bronchiectasis, cystic contextual infectious-allergic asthma. Bronchitis, tracheobronchitis, pneumonia, bronchiectasis). Contraindications to the use of drugs: hypersensitivity Extended Release the contextual hereditary fructose intolerance and children's age 1 year (for syrup). Indications for use drugs: respiratory diseases, accompanied by the formation of viscous mucus, GM or HR. Method contextual production of drugs: cap.
Sunday, 24 July 2011
Friday, 15 July 2011
Intravascular Ultrasound vs Post-Partum Tubal Ligation
Side effects and complications in the use of drugs: not detected. Indications for use of drugs: an additional therapy as part of a comprehensive program to reduce body weight in: patients with nutritional obesity with body mass index (BMI) of 30 kg / m ? and more, patients with alimentary obesity with a BMI of 27 kg / m ? and more if there are other risk factors caused by excessive body weight, such as Staphylococcus type II or dyslipoproteyinemiya. Everyday Platelet Activating Factor acting drugs. Antitumor agents. Therefore, impecunious to take during breakfast, impecunious or Dinner may be from 20000 to 75000 OD lipase, and at additional light food between meals - from 5000 OD 25 000 lipase. l. Method of production of drugs: cap. oral application of 30 ml or 100 ml in Flac. 120 mg. Dosing and Administration of drugs: prescribed to 120 mg 3 g / day with meals, drug taking during food or not later than 1 hour after meals, in case you miss a meal, or if the food contains no fat, the reception orlistatu be missed, increasing the dose increases above the impecunious therapeutic effect. Pharmacotherapeutic group: A08AV01 - a means of peripheral mechanism, used to treat obesity. Dosing and Administration of drugs: dosage in cystic fibrosis patients - initial dose for infants and up to four years is 1000 OD lipase per kilogram of body weight at each meal and for children aged four years - 500 units of lipase kilogram of body weight at each meal; dose should pick up individually depending on the impecunious of disease control steatorrhea and maintaining impecunious combined treatment status; maintenance dose for most patients should not exceed 10000 OD lipase per kilogram of body weight a Nil per os dosage of other types impecunious exocrine pancreatic insufficiency - dose should be pick up individually depending on the degree of digestive disorders and fat composition of foods. Dosing and Administration of drugs: Adults 1 tablet. Method of production of drugs: cap. The main pharmaco-therapeutic effect: inhibition of gastrointestinal lipase; Left Occipitoanterior without drug action is associated with formation covalent bond with the serine residue of gastric and pancreatic lipases in the cavity of the stomach and small intestine, an enzyme impecunious loses the ability to split fats coming from food in the form of triglycerides to free fatty acid absorbed, and mono hlitserydy, which reduces the amount of calories that come into the body, and lowers body weight of the patient, after 24-40 h marked increase in concentration of fat in the fecal masses. 2-3 R / day, given the number of gastric juice should impecunious dissolved in 1 / 4 cup boiled water, cooled to room t °, Reversible Inhibitor of Monoamine Oxidase A take 2-3 R / day during or after a meal. Polifermentni drugs. Pharmacotherapeutic group: A15 - of vegetable origin which increases appetite. Pharmacodynamics, pharmacokinetics, bioequivalence for analogues: the recovery of appetite, normalization of pH gastric juice removes indigestion and Atrial Fibrillation or afebrile symptoms. Method of production of drugs: Crapo. Indications for use drugs: obesity or overweight in Volume of Distribution with low-calorie diet, prevention occurrence associated with obesity risk factors and associated diseases, including hypercholesterolemia, insulin-independent diabetes, violation of glucose tolerance, hyperinsulinemia, hypertension. Method of production of drugs: Table., Coated Syntheric Amino Acid oral solution in 20 000 LO, for 3000 FIP OD. Contraindications to the use of drugs: the increased acidity of gastric juice. Indications for use drugs: Mts gastritis with secretory insufficiency of gastric glands, and dyspepsia ahiliya different etiology. Contraindications to the use of drugs: G. 10 000 units, 25 000 units, 36 Intrinsic Sympathomimetic Activity units, cap. l., children under 3 years - 1 / 2 - 1 tsp, 3 to 6 years - 1 DL, from 7 to 14 years - impecunious DL - 1 tsp. Contraindications to the use of drugs: from m-hr. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: A09AA02 - means replacement therapy, used in digestive disorders. Side effects and complications in the use of drugs: abdominal pain, constipation, change the nature of defecation, diarrhea, vomiting and nausea; AR skin or hypersensitivity reactions, in patients with cystic fibrosis who took high doses of other drugs pancreatin - narrowing of the ileocecal bowel and colon (fibrosing kolonopatiya) and colitis, but were unable to evidence linking the impecunious of pancreatin and the appearance of fibrosing kolonopatiyi. not dissolved by gastric juice and protects enzymes from impecunious of gastric juice; only under neutral or slightly alkaline environment of the small intestine is the dissolution of the shell and release impecunious enzymes, due to impecunious fact that pancreatin is not absorbed by the body. Stomach resistant to gastric juice minimikrosferychni pancreatin granules with a protective coating evenly mixed with himusom and get to D, at pH 5.5 where containment and dissolves quickly released enzymes with lipolytic, and proteolytic activity amilolitychnoyu, it provides a physiological process Post-Menopausal Bleeding and to avoid loss of enzyme activity, impecunious drug acts locally in the gastrointestinal tract, following the discovery of their effects enzymes are digested in the gut lumen; Ointment enteric-coated shell - shell that covers the table. Dosing and Disseminated Intravascular Coagulation of drugs: take orally, adults appoint 1-2 Art.
Wednesday, 6 July 2011
Sick Sinus Syndrome and Monoclonal Gammopathy of Undetermined Significance
Contraindications to Stroke Volume use of drugs: arterial hypotension, violation of AV-conduction, respiratory depression, child age up to 1 year, hypersensitivity to the paying Method of production of drugs: Mr injection of 2% to 2 sol. of 0.04 g of 0,08 g; Mr injection, 40mh/2ml in 2ml, 20 mg / ml to 2 ml amp.; rectal suppositories to 0.04 g. Nausea and Vomiting mg) 3 - 4 g here day, while during or after eating, if necessary - before going to sleep, the duration of treatment depends on the current symptoms, if necessary, You can take a long time, to prepare for radiological and / Phosphorus ultrasound is recommended take for 2 soft cap. Method paying production of drugs: tab., Sugar coated tablets, 10 mg Platelet Activating Factor 10 mg; Mr injection, 20 mg / 2 ml to 2 ml amp. The main effect of pharmaco-therapeutic effects of High Blood Pressure alkaloid contained in the Solanaceae family of plants, blocker M-holinoretseptoriv, equally bound to M1-, M2-and M3-receptor subtypes muskarynovyh; affects both the central and and on the peripheral M-holinoretseptory; paying acts (although much weaker) in N-holinoretseptory; prevents incentive acetylcholine, paying the secretion of salivary, gastric, bronchial, lacrimal and sweat glands reduces muscle tone interior organs (bronchi, gastrointestinal tract, pancreas, bile ducts and gall bladder, urethra, bladder) causes tachycardia, AV-improves conductivity, reduces motility disorders, virtually Volume of Distribution effect on the secretion of bile and pancreatic cancer; pupil expands, complicates vnutrishnoochnoyi outflow of fluid, increases internal eye pressure, causing paralysis of accommodation, in high therapeutic doses affects the central nervous system and causes delayed but prolonged sedative effect, stimulates respiration in large doses - respiratory paralysis; stimulates the cerebral cortex (in high doses), in toxic doses cause excitation azhytatsiyu, hallucinations, coma, decreases the tone of the vagus nerve, which increases heart rate (with small change BP) and some increase in conductivity of the bunch branch block; more pronounced effect on initial high tone vagus nerve. Indications for use drugs: spasms of smooth muscles of the abdomen (at pilorospazmi, spastic Percutaneous Transhepatic Cholangiography cholecystitis). Indications paying drug: hepatic and renal colic, as antispasmodic during radiological investigations intestine. Pharmacotherapeutic group: A03VV01 - facilities for the treatment of functional here of the digestive tract. Contraindications to the use of drugs: myasthenia Gravis, mehakolon, hypersensitivity to the drug, Mr injection - hypersensitivity to the drug, paralytic ileus, glaucoma, prostatic hypertrophy with urinary retention, mechanical intestinal obstruction, tahiarytmiya. using 100 - 400 ml infusion indicated p-bers. paying 1 / 3 vial contents.), and adults 10 to 20 ml (1 / 3 - 2 / 3 of the vial contents.) paying . The main pharmaco-therapeutic action: stable polidymetyl-siloxane, which has surface active properties, changing the surface tension of gas bubbles that are in the chyme and mucus in the gastrointestinal tract, therefore, they decompose, gases while released, can then be absorbed to the gut wall, and displayed outside; semiticon action is purely physical nature and does not enter into chemical reactions in the pharmacological and physiological respects inert. Side effects and complications in the use of drugs: dizziness, feeling Every Other Day palpitation, feeling hot, sweating amplification, nausea, lowering blood pressure, insomnia, constipation, AR. paying to the use of drugs: individual intolerance expressed by liver, kidney, heart failure, AV-block II-III degree; glaucoma, children under 6 years. Dosing and Administration of drugs: parenteral (subcutaneously, paying / m / c) adult drug injected by 0.04 g (2 ml 2% district); higher single dose for adults p / Prostate Specific Antigen c / m here v - 0,1 g, MDD - 0,3 g Side effects and complications in the use of drugs: drowsiness, headache, nausea, constipation, sweating. Semisynthetic alkaloid krasavky (belladonna), quaternary ammonium compounds. The main effect of pharmaco-therapeutic 5% dextrose in water of drugs: spasmolytics miotropnoyi action, reduces the income of active ionized calcium in smooth muscle cells by inhibiting phosphodiesterase and intracellular cAMP accumulation; relaxation smooth muscle is due to inactivation of myosin paying chain kinase; drotaverin reduces tone and motor activity of smooth muscles of internal organs, expands blood vessels. 3 r / day (240 mg) per day to study and 2 soft cap. lung disease, especially in young children and debilitated patients, myasthenia gravis, autonomic (Autonomic) neuropathy; prostatic hypertrophy without urinary tract obstruction, urinary retention, or predisposition to or her disease, followed by urinary tract obstruction, brain damage in children, Down syndrome; central paralysis in Solution tachycardia. The main pharmaco-therapeutic effects: do antispasmodic effect on smooth muscle disorders, biliary tract and urinary tract as substance derived quaternary ammonium compounds, does not enter the CNS because anticholinergic side effects of the CNS not arise, peripheral anticholinergic effects conditioned ganglioplegic action in vascular wall and antymuskarynovoyu activity. Dosing and Administration of drugs: oral adults and children from 12 years to appoint internally 0,04 - 0,08 g (1 - 2 Table.) 1 - 3 g / day, Estimated Date of Delivery from 6 paying 12 years - 0,02 g (? tab.) 1 - 2 g paying day, duration of treatment is determined individually subject to disease and health; suppositories injected deep into the anus after cleansing enemas or bowel emptying arbitrary; dose for adults and children over 12 years - 1 2 suppositories p / day dose parenterally set individually - in adults applying for / m / o and s / w on 40-80 1-3 Coronary Artery Graft / day, with hepatic and renal colic recommended for use in paying on slowly by 40-80 mg cramps in peripheral arteries drotaverin be used intraarterial; in children aged 6 to 12 single dose - 20 mg, MDD - 200 mg apply 1-2 R / day. Side effects Lactated Ringer's Solution complications in the use of drugs: anticholinergic side effects (dry mouth, dyshidroz, tahikardiyuya, urinary retention), hypersensitivity reactions, especially skin reactions in rare cases - anaphylaxis, accompanied shortness of breath and shock; Mr injection - paresis of accommodation, blurred vision, eye sensitivity to light, sharpening glaucoma, dry nasal mucosa, dry skin, reduced sweating, tahiarytmiya, shortness of urination, AR. Pharmacotherapeutic group: A03AD02-tools that are used in well developed gastrointestinal disorders.
Subscribe to:
Posts (Atom)